Gender differences in depression

Women's Health

Volumn 2, Issue 3, 2006, Pages 425-434

  Sloan, Denise M ^a   Sandt, Arthur R ^a  

^a TEMPLE UNIVERSITY   (United States)

Author keywords

Antidepressant pharmacotherapy; Cognitive behavioral therapy; Depression; Gender; Hormones; Prevalence; Stressful events

Indexed keywords

AMFEBUTAMONE; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; PAROXETINE; PHENELZINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

COMORBIDITY; DEPRESSION; DRUG RESPONSE; ENVIRONMENTAL FACTOR; FEMALE; GENERAL PRACTITIONER; HEALTH CARE PERSONNEL; HEREDITY; HUMAN; LIFE EVENT; MALE; MENTAL DISEASE; PREVALENCE; PSYCHOTHERAPY; REVIEW; SCREENING; SEX DIFFERENCE; STRESS; VULNERABLE POPULATION;

EID: 33646757569     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/17455057.2.3.425     Document Type: Review

References (61)

1. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). American Psychiatric Association, Washington, DC, USA (2000).
2. Kessler RC, Berglund P, Dernler O et al.: National comorbidity survey replication. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 289, 3095-3010 (2003).
3. Insel TR, Charney DS: Research on major depression: strategies and priorities. JAMA 289, 3167-3168 (2003).
4. Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder. Results from the national epidemiologic survey on alcoholism and related conditions. Arch. Gen. Psychiatry 62, 1097-1106 (2005).
5. Kessler RC: Epidemiology of women and depression. J. Affect. Disord. 74, 5-13 (2003).
6. Marcus SM, Young EA, Kerber KB et al.: Gender differences in depression: findings from the STAR*D study. J. Affect. Disord. 87, 141-150 (2005).
7. Kornstein KG: Gender, depression and antidepressant treatment. Primary Psychiatry 10(12), 58-61 (2003).
8. Nolen-Hoeksema S: Gender differences in depression. Curr. Dir. Psychological Sci. 10(5), 173-176 (2001).
9. Cyranowski JM, Frank E, Young E et al.: Adolescent onset of the gender difference in lifetime rates of major depression: a theoretical model. Arch. Gen. Psychiatry 57, 21-27 (2000).
10. Burt VK, Stein K: Epidemiology of depression throughout the female life cycle. J. Clin. Psychiatry 63(Suppl. 7), 9-15 (2002).
11. World Health Organization: Progress in reproductive health research. 56 (2000).
12. Hankin BL, Abramson LY. Development of gender differences in depression: an elaborated cognitive vulnerability-transactional stress theory. Psychol. Bull. 127(6), 773-796 (2001).
13. Angold A, Costello EJ, Worthman CM: Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol. Med 28(1), 51-61 (1998).
14. Hammen C: Stress and depression. Annu. Rev. Clin. Psychol. 1, 293-319 (2005).
15. Kendler KS, Gardner CO, Prescott CA: Toward a comprehensive developmental model for major depression in women. Am. J. Psychiatry 159(7), 1133-1145 (2002).
16. Maciejewski PK, Prigerson HG, Mazure CM: Sex differences in event-related risk for major depression. Psychol. Med. 31, 593-604 (2001).
17. Heim C. Nemeroff CB: The role of childhood trauma in the neurobiology of mood and anxiety disorders: preclinical and clinical studies. Biol. Psychiatry 49, 1023-1039 (2001).
18. Lee AL, Ogle WO, Sapolsky RM: Stress and depression: possible links to neuron death in the hippocampus. Bipolar Disord. 4, 117-128 (2002).
19. Ladd CO, Huot RL, Thrivikraman KV, Nemeroff CB, Meaney MJ, Plotsky PM: Long-term behavioral and neuroendocrine adaptations to adverse early experience. In: Progress in Brain Research. Mayer EA, Saper CB (Eds).Elsevier, NY, USA, 81-103 (2000).
20. Thase M, Jindal R, Howland R: Biological aspects of depression. In: Handbook of Depression. Hammen C, Gotlib I (Eds). Guilford Press, NY, USA, 192-218 (2002).
21. Caspi A, Sugden K, Moffitt TE et al.: Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386-389 (2003).
22. Lesch KP: Neuroticism and serotonin: a developmental genetic perspective In: Behavioral Genetics in the Postgenomics Era. Plomin R, DeFries IC, Craig IW, McGuffin P (Eds). American Psychological Association Publishing, Washington, DC, USA, 389-424 (2002).
23. Kendler KS, Kuhn JW, Vittum J, Prescott CA, Riley B: The interaction of stressful life events and a serotonin tranporter polymorphism in the prediction of episodes of depression. Arch. Gen. Pychiatry 62, 529-535 (2005).
24. Carter JD, Joyce PR, Mulder RT et al.: Gender differences in the presentation of depressed outpatients: a comparison of descriptive variables. J. Affect. Disord. 61, 59-67 (2000).
25. Kornstein SG, Schatzberg AF, Thase ME et al.: Gender differences in chronic major and double depression. J. Affect. Disord. 60, 1-11 (2000).
26. Blashki G, Pirkis J, Morgan H, Ciechomski L: Managing depression and suicide risk in men presenting to primary care physicians. Prim. Care 33(1), 211-212 (2006).
27. Rhodes A, Jaakkimainen R, Bondy S, Fung K: Depression and mental health visits to physicians - a prospective records-based study. Soc. Sci. Med. 62(4), 828-834 (2006).
28. Evans DL, Charney DS, Lewis L et al.: Mood disorders in the medically ill: scientific review and recommendations. Biol. Psychol. 58(3), 175-189 (2005).
29. Katon W, Unutzer J, Fan MY et al.: Cost-effectiveness and net benefit of enhanced treatment of depression for older adults with diabetes and depression. Diabetes Care 29(2), 265-270 (2006).
30. Robinson DA. Worell J: Issues in clinical assessment in women. In: Clinical Personality Assessment: Clinical Approaches (2nd Edition). Butcher JN (Ed.) Oxford University Press, New York, NY, USA, 190-207 (2002).
31. Kornstein SG, Sloan DM, Thase ME: Gender specific differences in depression and response to antidepressant treatment. Psychopharmacol. Bull. 36 (Suppl. 3), 99-112 (2002).
32. Aben I, Verhey F, Strik J, Lousberg R, Lodder J, Honig A: A comparative study into the one year cumulative incidence of depression after stroke and myocardial infarction. J. Neurol. Neurosurg. Psychiatr. 74(5), 581-585 (2003).
33. Cassidy E, O'Connor R, O'Keane V: Prevalence of post-stroke depression in an Irish sample and its relationship with disability and outcome following inpatient rehabilitation. Disabil. Rebahil. 26(2), 71-77 (2004).
34. Raison CL, Miller AH: Depression in cancer: new developments regarding diagnosis and treatment. Biol. Psychiatry 54, 283-294 (2003).
35. Spiegel D, Giese-Davis J: Depression and cancer: mechanisms and disease progression. Biol. Psychiatry 54(3), 269-282 (2003).
36. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ: The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 24(6). 1069-1078 (2001).
37. Iosifescu DV, Fragruas R: Antidepressant treatment in major depressive disorder with medical illness. Primary Psychiatry 12(5), 58-62 (2005).
38. Krishnan KR, Delong M, Kraemer H et al.: Comorbidity of depression with other medical diseases in the elderly. Biol. Psychiatry 52(6), 559-588 (2002).
39. Borland RJ, Keller MB: Course and outcome of depression. In: Handbook of Depression. Hammen C, Gotlib I (Eds). Guilford Press, New York, NY, USA, 43-60 (2002).
40. Smallwood-Fergerson SS, Jamieson DJ, Lindsay M: Diagnosing postpartum depression: can we do better? Am. J. Obstet. Gynecol. 186, 899-902 (2002).
41. Shea, MT, Elkin I, Sotsky SM: Patient characteristics associated with successful treatment: outcome findings from the NIMH Treatment of Depression Collaborative Research Program. In: Psychotherapy Indications and Outcomes. Janowsky DS (Ed.) American Psychiatric Press, Washington, DC, USA, 71-90 (1999).
42. Sloan DM, Kornstein SG: Gender differences in depression and response to antidepressant treatment. Psychiatr. Clin. N. Am. 26, 581-594 (2003).
43. Thase ME, Frank E, Kornstein SG, Yonkers KA: Gender differences in response to treatments of depression. In: Gender and its Effects on Psychopathology. Frank E (Ed.) American Psychiatric Press, Washington, DC, USA, 103-129 (2003).
44. Martenyi F, Dossenbach M, Mraz K et al.: Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile. Eur. Aeuropsychopharmacol. 11, 227-232 (2001).
45. Quitkin FM, Stewart JW, McGrath PJ et al.: Are there differences between women's and men's antidepressant responses? Am. J. Psychiatry 159, 1848-1854 (2002).
46. Hamilton JA, Grant M, Jensvold MF: Sex and treatment of depression: when does it matter? In: Psychopharmacology and Women. Sex, Cender and Hormones. Jensvold M, Halbreich U, Hamilton JA (Eds). American Psychiatric Press, Washington, DC, USA, 241-257 (1996).
47. Entsuah AR, Huang H, Thase ME: Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo. J. Clin. Psychiatry 62, 869-877 (2001).
48. Schmidt PJ, Nieman L, Danaceau MA: Estrogen replacement in perimenopause-related depression: a preliminary report. Am. J. Obstet. Gynecol. 183, 414-420 (2000).
49. Soares CN, Almeida OP Joffe H et al.: Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women. Arch. Gen. Psychiatry 58, 529-534 (2001).
50. Women's Health Initiative Study Group: Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288, 321-333 (2002).
51. Gapstur SM, Morrow M, Sellars TA: Hormone replacement therapy and risk of breast cancer with favorable histology: results of the Iowa women's health study. JAMA 281, 2091-2097 (1999).
52. Pickar JH, Thorneycroft I, Whitehead M: Effects of hormone replacement therapy on the endometrium and lipid parameters. A review of the randomized clinical trials. Am. J. Obstet. Gynecol. 178, 1-25 (1998).
53. Hotopf M, Chidgey J, Addington-Hall J, Ly KL: Depression in advanced disease: a systematic review. Part 1 Prevalence and case finding. Palliat. Med. 16, 81-97 (2002).
54. Strik JJ, Honig A, Lousberg R et al.: Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial. Psychosom. Med. 62(6), 783-789 (2000).
55. Glassman AH, O'Connor CM, Califf RM et al. for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group: Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA 288(6), 701-709 (2002).
56. Robinson RG, Schultz SK, Castillo C et al.: Nortriptyline versus fluoxetine in the treatment of depression and in short-term recovery after stroke: a placebo-controlled, double-blind study. Am. J. Psychiatry 57(3), 351-359 (2000).
57. Lustman PJ, Freedland KE, Griffith LS, Clouse RE: Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial. Diabetes Care 23(5), 618-623 (2000).
58. Fava M: Augmentation and combination strategies in treatment-resistant depression. J. Clin. Psychiatry 62(Suppl. 18), 4-11 (2001).
59. Koike AK, Unutzer J, Wells KB: Improving the care for depression in patients with comorbid medical illness. Am. J. Psychiatry 159(10), 1738-1745 (2002).
60. Berkman LF, Blumenthal J, Burg M et al.: Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA 289(23), 3106-3116 (2003).
61. Calabrese JR, Markovitz PJ: Treatment of depression. New pharmacologic approaches. Prim. Care 18(2), 421-433 (1991).